KAT6B is required for histone 3 lysine 9 acetylation and SOX gene expression in the developing brain
Life Science Alliance · 2025-02 · 8 (2) · e202402969
DOI: 10.26508/lsa.202402969 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 13.11.2024. Verfasst von Maria I Bergamasco und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia. Hauptthemen laut MEDLINE: Histones, Histone Acetyltransferases, Neural Stem Cells, Brain. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pamela and Lorenzo Galli Charitable Trust, Australian National Health and Medical Research Council, Chan Zuckerberg Initiative.
Abstract (Originalsprache)
Heterozygous mutations in the histone lysine acetyltransferase gene KAT6B ( MYST4/MORF/QKF ) underlie neurodevelopmental disorders, but the mechanistic roles of KAT6B remain poorly understood. Here, we show that loss of KAT6B in embryonic neural stem and progenitor cells (NSPCs) impaired cell proliferation, neuronal differentiation, and neurite outgrowth. Mechanistically, loss of KAT6B resulted in reduced acetylation at histone H3 lysine 9 and reduced expression of key nervous system development genes in NSPCs and the developing cortex, including the SOX gene family, in particular Sox2 , which is a key driver of neural progenitor proliferation, multipotency and brain development. In the fetal cortex, KAT6B occupied the Sox2 locus. Loss of KAT6B caused a reduction in Sox2 promoter activity in NSPCs. Sox2 overexpression partially rescued the proliferative defect of Kat6b −/− NSPCs. Collectively, these results elucidate molecular requirements for KAT6B in brain development and identify key KAT6B targets in neural precursor cells and the developing brain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
- Department of Medical Biology, The University of Melbourne, Parkville, Australia.
- School of Mathematics and Statistics, University of Melbourne, Parkville, Australia.
- The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia tthomas@wehi.edu.au.
- The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia avoss@wehi.edu.au.
ORCID-Profile: Connie Sn Li-Wai-Suen, Tim Thomas, Anne K Voss
Förderung
- Pamela and Lorenzo Galli Charitable Trust
- Australian National Health and Medical Research Council
- Chan Zuckerberg Initiative
- The Galli Trust
Zitieren
APA
Bergamasco, M. I., Abeysekera, W., Garnham, A. L., Hu, Y., Li-Wai-Suen, C. S., Sheikh, B. N., Smyth, G. K., Thomas, T., & Voss, A. K. (2025). KAT6B is required for histone 3 lysine 9 acetylation and SOX gene expression in the developing brain. Life Science Alliance, 8(2), e202402969. https://doi.org/10.26508/lsa.202402969
Vancouver
Bergamasco MI, Abeysekera W, Garnham AL, Hu Y, Li-Wai-Suen CS, Sheikh BN, et al. KAT6B is required for histone 3 lysine 9 acetylation and SOX gene expression in the developing brain. Life Science Alliance. 2025;8(2):e202402969. doi:10.26508/lsa.202402969
BibTeX
@article{Bergamasco2025,
author = {Bergamasco, Maria I and Abeysekera, Waruni and Garnham, Alexandra L and Hu, Yifang and Li-Wai-Suen, Connie Sn and Sheikh, Bilal N and Smyth, Gordon K and Thomas, Tim and Voss, Anne K},
title = {KAT6B is required for histone 3 lysine 9 acetylation and SOX gene expression in the developing brain},
journal = {Life Science Alliance},
year = {2025},
volume = {8},
number = {2},
pages = {e202402969},
doi = {10.26508/lsa.202402969}
}
EUVIMED